[September 26, 2005] Phase Forward Named to Deloitte's New England Technology Fast 50 Tweet WALTHAM, Mass. --(Business Wire)-- Sept. 26, 2005 -- Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that it has been named to Deloitte's prestigious Technology Fast 50 program. A ranking of the 50 fastest growing technology companies in the New England region area based on the percentage revenue growth over five years from 2000-2004, Phase Forward achieved the 27th position in Deloitte's listing. Stephen DiPietro, a partner at Deloitte & Touche LLP and chairman of Deloitte's New England Technology Fast 50 program, remarked, "Sustaining high revenue growth over five years is an exceptional accomplishment. We commend Phase Forward for making the commitment to technology and delivering on the promise of market longevity, and are proud to honor the company as a Deloitte Technology Fast 50 winner." The Fast 50 award comes during a highly successful period for Phase Forward. For the first half of 2005, the company reported record revenue growth and earnings, in addition to multiple new customer engagements such as Dana Farber Cancer Institute and Philips Oral Healthcare. In April, the company launched a new version of its flagship web-based electronic data capture (EDC) solution, InForm(TM) ITM, which received the prestigious "Best of Show" award at the 2005 Bio-IT World conference based on its innovative nature, technical merit, and functionality in the clinical trials process. In July, Phase Forward announced a joint offering with SAS(R) Drug Development to streamline work processes for enterprise level implementation across the drug development continuum. In August, the company completed the acquisition of Lincoln Technologies, which adds pharmacovigilance, data standardization, and safety signal detection technology to the company's current solutions. "Phase Forward's success can be attributed to our superior technology offering, commitment from our valued customer base, and the 400 outstanding people who make up our team," said Bob Weiler, president and chief executive officer of Phase Forward. "Recognition by Deloitte as one of New England's fastest growing companies underscores the long-term sustainability and broad market acceptance of our solutions. We are pleased to have secured our ranking and honored to be among such a successful group of growing technology companies in New England." Winners of the 15 regional Technology Fast 50 programs in the United States and Canada are automatically entered in Deloitte's Technology Fast 500 program, which ranks North America's top 500 fastest growing technology companies. About Phase Forward Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. The company offers proven solutions in electronic data capture (EDC), clinical data management (CDM), and adverse event reporting (AER) to help pharmaceutical, biotechnology, and medical device companies bring needed drugs and therapies to market faster and more safely. Lincoln Technologies, acquired by Phase Forward in August of 2005, delivers solutions for pharmacovigilance, data standardization, and safety signal detection. The combined companies' products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 220 organizations and regulatory agencies worldwide including: AstraZeneca, Biogen Idec, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, FDA, GlaxoSmithKline, Guidant, MHRA, NIH, Procter & Gamble, Quintiles, Sanofi-Aventis, Schering-Plough Research Institute, and Serono. Additional information about Phase Forward is available at www.phaseforward.com. About Deloitte Deloitte refers to one or more of Deloitte Touche Tohmatsu, a Swiss Verein, its member firms and their respective subsidiaries and affiliates. As a Swiss Verein (association), neither Deloitte Touche Tohmatsu nor any of its member firms has any liability for each other's acts or omissions. Each of the member firms is a separate and independent legal entity operating under the names "Deloitte", "Deloitte & Touche", "Deloitte Touche Tohmatsu" or other related names. Services are provided by the member firms or their subsidiaries or affiliates and not by the Deloitte Touche Tohmatsu Verein. Deloitte & Touche USA LLP is the US member firm of Deloitte Touche Tohmatsu. In the US, services are provided by the subsidiaries of Deloitte & Touche USA LLP (Deloitte & Touche LLP, Deloitte Consulting LLP, Deloitte Financial Advisory Services LLP, Deloitte Tax LLP and their subsidiaries), and not by Deloitte & Touche USA LLP. [ Back To TMCnet.com's Homepage ]